The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...
On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...
Insignia Financial is now entertaining a trio of suitors after Brookfield Capital Partners joined the fight for the wealth ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
Monroe Capital will open a Sydney office and has tapped former Hines Investment Management’s capital markets director Galen ...
TOKYO (Reuters) - U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share ...
BOSTON - Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a business development company with a market capitalization of $1 ...
Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the "Company") today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% senior notes due 2030 (the "Notes ...